In the aftermath of Marc Cuban’s oped from two days ago, that the current, second tech bubble is worse than the first dot com bubble of 2000, there has been much anguish by those deeply invested (on margin) in (bio)tech stocks, to demonstrate that the Nasdaq at 5000, or Biotechs trading at 50x or 5000xP/E, is perfectly normal and the global central banks’ $13 trillion in liquidity has nothing to do with it.